Research Articles | Page 15 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Telomere length in hematopoietic stem cell transplantation for severe aplastic anemia: is it ready for "prime time"? Feb 2015 JAMA aplastic anemia
Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes Apr 2014 Leuk Res myelodysplastic syndromes (MDS)
Tea consumption reduces the risk of de novo myelodysplastic syndromes Dec 2014 Leuk Res myelodysplastic syndromes (MDS)
Targeting TP53 Mutations in Myelodysplastic Syndromes Apr 2020 Hematology/oncology clinics of North America myelodysplastic syndromes (MDS)
Targeting the Microenvironment in MDS: The Final Frontier Jul 2020 Frontiers in Pharmacology myelodysplastic syndromes (MDS)
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R Sep 2017 Am J Hematol myelodysplastic syndromes (MDS)
T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways Jun 2017 J Immunol paroxysmal nocturnal hemoglobinuria (PNH)
T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways Jul 2017 Journal of Immunology paroxysmal nocturnal hemoglobinuria (PNH)
Syngeneic transplantation in aplastic anemia: pretransplant conditioning and peripheral blood are associated with improved engraftment - an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Jul 2013 Haematologica aplastic anemia
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes Dec 2020 Hematology/oncology and stem cell therapy acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Share with addtoany.com.